| Outbreak of Mycoplasma pneumoniae–Associated Stevens-Johnson Syndrome D Olson, LKF Watkins, A Demirjian, X Lin, CC Robinson, K Pretty, ... Pediatrics 136 (2), e386-e394, 2015 | 113 | 2015 |
| Long-term survival and cost-effectiveness associated with axicabtagene ciloleucel vs chemotherapy for treatment of B-cell lymphoma MD Whittington, RB McQueen, DA Ollendorf, VM Kumar, RH Chapman, ... JAMA network open 2 (2), e190035-e190035, 2019 | 96 | 2019 |
| Long-term survival and value of chimeric antigen receptor T-cell therapy for pediatric patients with relapsed or refractory leukemia MD Whittington, RB McQueen, DA Ollendorf, VM Kumar, RH Chapman, ... JAMA pediatrics 172 (12), 1161-1168, 2018 | 94 | 2018 |
| Cost-effectiveness of biological asthma treatments: a systematic review and recommendations for future economic evaluations RB McQueen, DN Sheehan, MD Whittington, JFM van Boven, ... Pharmacoeconomics 36, 957-971, 2018 | 90 | 2018 |
| Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis MD Whittington, RB McQueen, DA Ollendorf, JA Tice, RH Chapman, ... Annals of Allergy, Asthma & Immunology 118 (2), 220-225, 2017 | 85 | 2017 |
| Aducanumab for Alzheimer’s disease: effectiveness and value; final evidence report and meeting summary GA Lin, MD Whittington, PG Synnott, A McKenna, J Campbell, ... Institute for Clinical and Economic Review 5, 2021 | 60 | 2021 |
| Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver survey JD Campbell, MD Whittington, CH Kim, GR VanderVeen, KG Knupp, ... Epilepsy & behavior 80, 152-156, 2018 | 58 | 2018 |
| Cost-effectiveness and value-based pricing of aducanumab for patients with early Alzheimer disease MD Whittington, JD Campbell, D Rind, N Fluetsch, GA Lin, SD Pearson Neurology 98 (9), e968-e977, 2022 | 45 | 2022 |
| The direct and indirect costs of Dravet Syndrome MD Whittington, KG Knupp, G Vanderveen, C Kim, A Gammaitoni, ... Epilepsy & Behavior 80, 109-113, 2018 | 34 | 2018 |
| Recommendations for methicillin-resistant Staphylococcus aureus prevention in adult ICUs: a cost-effectiveness analysis MD Whittington, AJ Atherly, DJ Curtis, RC Lindrooth, CJ Bradley, ... Critical care medicine 45 (8), 1304-1310, 2017 | 28 | 2017 |
| The cost-effectiveness of remdesivir for hospitalized patients with COVID-19 MD Whittington, SD Pearson, DM Rind, JD Campbell Value in Health 25 (5), 744-750, 2022 | 27 | 2022 |
| RCT of centralized vaccine reminder/recall for adults LP Hurley, B Beaty, S Lockhart, D Gurfinkel, K Breslin, M Dickinson, ... American Journal of Preventive Medicine 55 (2), 231-239, 2018 | 25 | 2018 |
| Valuing chimeric antigen receptor T-cell therapy: current evidence, uncertainties, and payment implications MD Whittington, RB McQueen, JD Campbell Journal of Clinical Oncology 38 (4), 359-366, 2020 | 24 | 2020 |
| Aducanumab for Alzheimer’s disease: effectiveness and value; draft evidence report GA Lin, MD Whittington, PG Synnott, A McKenna, J Campbell, ... Institute for Clinical and Economic Review 5, 2021 | 23 | 2021 |
| Impact of nonmedical vaccine exemption policies on the health and economic burden of measles MD Whittington, A Kempe, A Dempsey, R Herlihy, JD Campbell Academic Pediatrics 17 (5), 571-576, 2017 | 23 | 2017 |
| Alternative pricing models for remdesivir and other potential treatments for COVID-19; updated report JD Campbell, MD Whittington, DM Rind, SD Pearson Institute for Clinical and Economic Review, 2020 | 20 | 2020 |
| The effectiveness and value of aducanumab for Alzheimer’s disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum PG Synnott, MD Whittington, GA Lin, DM Rind, SD Pearson Journal of Managed Care & Specialty Pharmacy 27 (11), 1613-1617, 2021 | 19 | 2021 |
| Effect of state immunization information system centralized reminder and recall on HPV vaccination rates P Szilagyi, C Albertin, D Gurfinkel, B Beaty, X Zhou, S Vangala, J Rice, ... Pediatrics 145 (5), 2020 | 19 | 2020 |
| The effectiveness and value of biologic therapies for the treatment of uncontrolled asthma: A summary from the institute for clinical and economic review’s midwest comparative … JA Tice, JD Campbell, PG Synnott, JME Walsh, VM Kumar, M Whittington, ... Journal of Managed Care & Specialty Pharmacy 25 (5), 510-514, 2019 | 19 | 2019 |
| Living health technology assessment: issues, challenges and opportunities P Thokala, T Srivastava, R Smith, S Ren, MD Whittington, J Elvidge, ... PharmacoEconomics 41 (3), 227-237, 2023 | 17 | 2023 |
R. Brett McQueenUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences在 ucdenver.edu 的电子邮件经过验证
R. Brett McQueenUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences在 ucdenver.edu 的电子邮件经过验证
Jonathan D CampbellNational Pharmaceutical Council